Published in Obes Surg on March 01, 2015
Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab (2006) 2.78
A burning question: does an adipokine-induced activation of the immune system mediate the effect of overnutrition on type 2 diabetes? Diabetes (2005) 2.30
Microangiopathy of large artery wall: a neglected complication of diabetes mellitus. Atherosclerosis (2013) 2.03
Progressive loss of beta-cell function leads to worsening glucose tolerance in first-degree relatives of subjects with type 2 diabetes. Diabetes Care (2007) 1.91
Autoimmune cytopenia in chronic lymphocytic leukemia: prevalence, clinical associations, and prognostic significance. Blood (2010) 1.86
Causes and predictors of nonresponse to treatment of intensive care unit-acquired pneumonia. Crit Care Med (2004) 1.62
Interleukin 6, a nuclear factor-kappaB target, predicts resistance to docetaxel in hormone-independent prostate cancer and nuclear factor-kappaB inhibition by PS-1145 enhances docetaxel antitumor activity. Clin Cancer Res (2006) 1.61
Ghrelin attenuates hepatocellular injury and liver fibrogenesis in rodents and influences fibrosis progression in humans. Hepatology (2010) 1.61
GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects. Obes Surg (2006) 1.60
Long-term effects of sleeve gastrectomy and Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus in morbidly obese subjects. Ann Surg (2012) 1.60
Efficacy of linezolid compared to vancomycin in an experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated pigs. Crit Care Med (2012) 1.54
HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases. Tumour Biol (2011) 1.50
Increased dietary fat promotes islet amyloid formation and beta-cell secretory dysfunction in a transgenic mouse model of islet amyloid. Diabetes (2003) 1.49
Impact of ultrasensitive cardiac troponin I dynamic changes in the new universal definition of myocardial infarction. Am J Clin Pathol (2008) 1.45
Extramedullary multiple myeloma escapes the effect of thalidomide. Haematologica (2004) 1.42
Evaluation of accessibility and use of new communication technologies in patients with type 1 diabetes mellitus. J Med Internet Res (2002) 1.39
[Post-transplantation vaccination of bone-marrow transplant recipients]. Med Clin (Barc) (2002) 1.39
[Susceptibility to varicella among health care workers. Acceptability and response to vaccination]. Med Clin (Barc) (2011) 1.38
The 24-h carbohydrate oxidation rate in a human respiratory chamber predicts ad libitum food intake. Am J Clin Nutr (2007) 1.37
Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases. Clin Chem (2011) 1.30
Monoclonal gammopathy of undetermined significance: predictors of malignant transformation and recognition of an evolving type characterized by a progressive increase in M protein size. Mayo Clin Proc (2007) 1.27
Vitamin D, PTH, and the metabolic syndrome in severely obese subjects. Obes Surg (2008) 1.25
Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as tumor markers in patients with lung cancer: comparison with CYFRA 21-1, CEA, SCC and NSE. Tumour Biol (2008) 1.17
GLP-1 action and glucose tolerance in subjects with remission of type 2 diabetes after gastric bypass surgery. Diabetes Care (2013) 1.15
Emergence of oligoclonal bands in patients with multiple myeloma in complete remission after induction chemotherapy: association with the use of novel agents. Haematologica (2010) 1.14
Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-En-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects. Surg Endosc (2012) 1.11
Acute insulin response is an independent predictor of type 2 diabetes mellitus in individuals with both normal fasting and 2-h plasma glucose concentrations. Diabetes Metab Res Rev (2007) 1.11
Predictive factors of excess body weight loss 1 year after laparoscopic bariatric surgery. Surg Endosc (2012) 1.06
Short-term effects of gastric bypass surgery on circulating ghrelin levels. Obes Res (2004) 1.06
Long-term dietary intake and nutritional deficiencies following sleeve gastrectomy or Roux-En-Y gastric bypass in a mediterranean population. J Acad Nutr Diet (2013) 1.05
Elevation of serum levels of the anti-inflammatory cytokine interleukin-10 and decreased risk of coronary events in patients with unstable angina. Am Heart J (2002) 1.04
Circulating peptide YY, weight loss, and glucose homeostasis after gastric bypass surgery in morbidly obese subjects. Ann Surg (2008) 1.04
Bone marrow angiogenesis and angiogenic factors in multiple myeloma treated with novel agents. Cytokine (2008) 1.04
Revisional surgery after sleeve gastrectomy. Surg Laparosc Endosc Percutan Tech (2010) 1.04
Glucagon-like peptide 1 reduces endothelial dysfunction, inflammation, and oxidative stress induced by both hyperglycemia and hypoglycemia in type 1 diabetes. Diabetes Care (2013) 1.03
A strong initial systemic inflammatory response is associated with higher corticosteroid requirements and longer duration of therapy in patients with giant-cell arteritis. Arthritis Rheum (2002) 1.03
Usefulness of serum tumor markers, including progastrin-releasing peptide, in patients with lung cancer: correlation with histology. Tumour Biol (2009) 1.00
Clinical and inflammatory markers in amniotic fluid as predictors of adverse outcomes in preterm premature rupture of membranes. Am J Obstet Gynecol (2011) 0.99
Pro-gastrin-releasing peptide (proGRP) in patients with benign and malignant diseases: comparison with CEA, SCC, CYFRA 21-1 and NSE in patients with lung cancer. Anticancer Res (2005) 0.98
ProGRP: a new biomarker for small cell lung cancer. Clin Biochem (2004) 0.98
Nuclear factor-kappa B and interleukin-6 related docetaxel resistance in castration-resistant prostate cancer. Prostate (2012) 0.97
Insulin resistance, inflammation, and the metabolic syndrome following Roux-en-Y gastric bypass surgery in severely obese subjects. Diabetes Care (2007) 0.97
Protein intake, body composition, and protein status following bariatric surgery. Obes Surg (2010) 0.96
Evaluation of tumor markers (HER-2/neu oncoprotein, CEA, and CA 15.3) in patients with locoregional breast cancer: prognostic value. Tumour Biol (2010) 0.96
Predictive value of combined amniotic fluid proteomic biomarkers and interleukin-6 in preterm labor with intact membranes. Am J Obstet Gynecol (2009) 0.95
Th1/Th2 cytokine imbalance in patients with Sjögren syndrome secondary to hepatitis C virus infection. Semin Arthritis Rheum (2002) 0.94
Vitamin C further improves the protective effect of glucagon-like peptide-1 on acute hypoglycemia-induced oxidative stress, inflammation, and endothelial dysfunction in type 1 diabetes. Diabetes Care (2013) 0.94
Natural history and prognostic impact of oligoclonal humoral response in patients with multiple myeloma after autologous stem cell transplantation: long-term results from a single institution. Haematologica (2013) 0.94
Nutritional intake and prevalence of nutritional deficiencies prior to surgery in a Spanish morbidly obese population. Obes Surg (2011) 0.94
Genetic background determines the extent of islet amyloid formation in human islet amyloid polypeptide transgenic mice. Am J Physiol Endocrinol Metab (2005) 0.92
CA 19-9 in pancreatic cancer: retrospective evaluation of patients with suspicion of pancreatic cancer. Tumour Biol (2011) 0.92
Utility of serum tumor markers as an aid in the differential diagnosis of patients with clinical suspicion of cancer and in patients with cancer of unknown primary site. Tumour Biol (2011) 0.91
Inflammatory responses in blood samples of human immunodeficiency virus-infected patients with pulmonary infections. Clin Diagn Lab Immunol (2004) 0.89
Pro-gastrin-releasing peptide in patients with benign and malignant diseases. Tumour Biol (2004) 0.88
Clinical utility of %p2PSA and prostate health index in the detection of prostate cancer. Clin Chem Lab Med (2014) 0.88
GLP-1 and the long-term outcome of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery in morbidly obese subjects. Ann Surg (2013) 0.88
Prospective evaluation of squamous cell carcinoma and carcinoembryonic antigen as prognostic factors in patients with cervical cancer. Tumour Biol (2003) 0.87
Prospective evaluation of carcinoembryonic antigen (CEA) and carbohydrate antigen 15.3 (CA 15.3) in patients with primary locoregional breast cancer. Clin Chem (2010) 0.86
Lower total fasting plasma adiponectin concentrations are associated with higher metabolic rates. J Clin Endocrinol Metab (2006) 0.86
Type 2 diabetes-associated carotid plaque burden is increased in patients with retinopathy compared to those without retinopathy. Cardiovasc Diabetol (2015) 0.86
Protein intake and lean tissue mass retention following bariatric surgery. Clin Nutr (2012) 0.85
Neuromuscular dysfunction in adult growth hormone deficiency. Clin Endocrinol (Oxf) (2003) 0.85
Association analyses of variants in the DIO2 gene with early-onset type 2 diabetes mellitus in Pima Indians. Thyroid (2011) 0.85
Effect of hemodialysis and renal failure on serum biochemical markers of bone turnover. J Bone Miner Metab (2004) 0.85
Weight loss independently predicts urinary albumin excretion normalization in morbidly obese type 2 diabetic patients undergoing bariatric surgery. Surg Endosc (2013) 0.85
Commitment, enjoyment and motivation in young soccer competitive players. Span J Psychol (2010) 0.85
Prevalence of the metabolic syndrome in Spain using regional cutoff points for waist circumference: the di@bet.es study. Acta Diabetol (2013) 0.85
The effect of insulin on net lipid oxidation predicts worsening of insulin resistance and development of type 2 diabetes mellitus. Am J Physiol Endocrinol Metab (2007) 0.85
Effects of milk supplementation with conjugated linoleic acid (isomers cis-9, trans-11 and trans-10, cis-12) on body composition and metabolic syndrome components. Br J Nutr (2007) 0.85
Pulmonary infiltrates in patients receiving long-term glucocorticoid treatment: etiology, prognostic factors, and associated inflammatory response. Chest (2003) 0.85
Patterns of Weight Loss Response Following Gastric Bypass and Sleeve Gastrectomy. Obes Surg (2015) 0.85
Glucose response to an oral glucose tolerance test predicts weight change in non-diabetic subjects. Obesity (Silver Spring) (2007) 0.84
Differences in the etiology of community-acquired pneumonia according to site of care: a population-based study. Respir Med (2007) 0.84
Pica secondary to iron deficiency 1 year after gastric bypass. Surg Obes Relat Dis (2009) 0.84
Cytokine-release patterns in elderly patients with systemic inflammatory response syndrome. Gerontology (2007) 0.84
Endoscopic dilation with Savary-Gilliard bougies of stomal strictures after laparosocopic gastric bypass in morbidly obese patients. Obes Surg (2008) 0.83
CYFRA 21.1 in patients with cervical cancer: comparison with SCC and CEA. Anticancer Res (2005) 0.83
[Overweight and obesity in adults: recommendations and treatment algorithms]. Med Clin (Barc) (2004) 0.83
Intra-abdominal fat adiponectin receptors expression and cardiovascular metabolic risk factors in obesity and diabetes. Obes Surg (2006) 0.83
Calcium and vitamin D supplementation after gastric bypass should be individualized to improve or avoid hyperparathyroidism. Obes Surg (2010) 0.83
Relationship of p53 with other oncogenes, cytokines and systemic lupus erythematosus activity. Tumour Biol (2003) 0.82
Factors determining high-sensitivity C-reactive protein values in the Spanish population. Di@bet.es study. Eur J Clin Invest (2012) 0.82
Remission of type 2 diabetes after Roux-en-Y gastric bypass or sleeve gastrectomy is associated with a distinct glycemic profile. Ann Surg (2015) 0.82
Metabolic effects of bariatric surgery in insulin-sensitive morbidly obese subjects. Obes Surg (2013) 0.82
Prognostic impact of serum immunoglobulin heavy/light chain ratio in patients with multiple myeloma in complete remission after autologous stem cell transplantation. Biol Blood Marrow Transplant (2012) 0.82